Nonfatal Overdoses: All Stimulants

The drug overdose data presented below come from CDC’s Drug Overdose Surveillance and Epidemiology (DOSE) system. CDC has analyzed data from syndromic surveillance of suspected drug overdoses. Data presented here include percent change estimates in rates of suspected all stimulant overdoses per 10,000 ED visits. These suspected all stimulant overdose percent change estimates may change as CDC receives updated data, so estimates should be interpreted with caution.

The map below provides annual percent change estimates in rates of all stimulant overdoses per 10,000 ED visits for the most recent month of data. The “About This Map” section provides the specific data for the map and also all other annual percent change estimates. The other tables provide annual and monthly percent change estimates overall, by state, and by sex and age group.

Trends in Emergency Department Visits for Suspected All Stimulant Overdose, January 2019 to January 2020

CDC’s Drug Overdose Surveillance and Epidemiology (DOSE) System:* Annual Trends in Emergency Department Visits for Suspected All Stimulant Overdose§, January 2018 to January 2020, by OD2A-funded Jurisdiction

Download Dataexcel icon

January 2018 to January 2019 February 2018 to
February 2019
March 2018 to March 2019 April 2018 to April 2019 May 2018 to May 2019 June 2018 to June 2019 July 2018 to July 2019 August 2018 to
August 2019
September 2018 to September 2019 October 2018 to October 2019 November 2018 to November 2019 December 2018 to December 2019 January 2019 to January 2020 Category, January 2019 to January 2020
CDC’s Drug Overdose Surveillance and Epidemiology (DOSE) System:* Annual Trends† in Emergency Department Visits for Suspected All Stimulant Overdose§, January 2018 to January 2020,¶ by OD2A-funded Jurisdiction
Number of States 32 33 35 35 35 35 36 36 36 37 36 36 36
Overall 23.19 18.82 9.98 15.93 20.02 27.35 18.06 18.09 22.33 40.24 26.27 21.78 23.04 significant increase
State                          
Alabama 59.95 -0.58 37.72 6.88 51.91 21.83 11.18 1.67 -12.87 32.68 -15.36 29.43 -29.59 no significant change
Alaska
Arizona -4.15 16.76 -9.63 -9.76 2.23 17.68 -3.29 -15.52 -6.61 10.39 -19.26 -31.91 -18.31 no significant change
Arkansas 5.33 -6.6
California**
Colorado -4.59
Connecticut†† -9.43 48.34 30.02 73.67 -9.85
Delaware†† 11.31 -16.49 32.91 no significant change
District of Columbia 89.2 20.46 32.45 5.78 49.12 7.2 3.17 -9.74 32.49 23.07 -27.03 no significant change
Florida 32.42 24.75 28.59 22.05 29.57 42.36 29.21 21.67 50.58 77 55.82 47.95 53.56 significant increase
Georgia 22.13 3.14 -30.02 3.89 36.06 20.94 -13.69 -2.23 -10.04 -1.98 -1.9 -15.25 -29.91 no significant change
Hawaii**
Idaho††
Illinois 34.38 10.93 -22.69 22.75 3.12 22.56 12.77 8.01 17.87 8.93 -3.11 -10.22 -8.5 no significant change
Indiana 35.24 22.57 6.33 -4.95 12.17 1.36 30.83 11.86 1.71 6.05 -0.25 5.43 32.35 significant increase
Iowa**
Kansas -11.85 -7.3 -4.07 35.33 -24.96 18.89 7.11 -21.73 -10.04 -14.68 -24.99 7.1 52.31 no significant change
Kentucky††
Louisiana -13.82 -12.7 44.61
Maine
Maryland†† 22.12 -11.57 -4.96 2.39 8.57 35.46 19.69 19.8 7.99
Massachusetts 35.7 -28.77 -6.6 -21.85 -11.71 -11.43 7.79 -8.64 -6.61 11.58 40.88 47.81 19.73 no significant change
Michigan 28.49 134.92 60.41 42.56 90.06 97.62 46.21 83.34 103.36 100.66 64.49 147.82 62.66 significant increase
Minnesota**
Mississippi††
Missouri 12.67 74.77 11.06 5.88 -19.58 -0.59 1.04 1.95
Montana
Nebraska**
Nevada -24.54 30.89 43.12 2.7 -8.78 50.66 28.94 21.86 3.48 8.51 -3.56 37.58 24.06 no significant change
New Hampshire 19.33 -11.26
New Jersey -4.97 13.18 -4.57 no significant change
New Mexico -1.94 17.05 15.63 -31.15 -5.81 -1.93
New York State 0.2 22.38 22.38 24.5 14.69 18.63 -2.37 61.33 19.13 14.54 56.34 73.38 66.37 significant increase
North Carolina 12.72 -14.35 -6.72 -19.4 -18.76 -15.64 -5.11 -11.65 -28.96 6.69 -15.1 -11.92 -9.93 no significant change
North Dakota§§
Ohio 41.16 3.27 -27.37 26.9 -13.03 -20.8 -5.61 -8.99 14.21 19.76 -1.73 9.96 -13.5 no significant change
Oklahoma**
Oregon -14.06 -12.3 -0.58 23.31 -4.44 -5.02 -15.12 10.82 -52.28 5.22 -13.79 17.11 no significant change
Pennsylvania 20.88 42.17 -20.32 11.49 -4.33 17.2 3.7 2.74 -7.31 74.86 17.61 -18.23 26.75 no significant change
Puerto Rico**
Rhode Island††
South Carolina††
South Dakota
Tennessee 25.36 51.8 -7.7 27.97 17.74 23.14 31.1 13.4 7.19 10.16 -8.88 -2.4 12.37 no significant change
Texas§§
Utah -16.56 51.26 121.35 48.78 -15.66 7.08 -14.65 -42.9 -1.36 44.18 14.42 12.3 15.08 no significant change
Vermont
Virginia 58.32 5.64 32.18 40.31 22.35 16.05 -4.72 23.92 8.14 69.67 43.1 -74.66 -84.36 significant decrease
Washington -15.26 -36.17 -5.73 -17.51 17.84 62.13 52.87 194.27 181.86 89.98 66.04 104.11 87.66 significant increase
West Virginia†† 30.01
Wisconsin†† 38.45
Wyoming§§

 

* See DOSE System page.

† To account for changes occurring across time, annual trends for the rate of ED visits involving suspected drug overdoses (e.g., ED visits involving drug overdoses divided by total ED visits and multiplied by 10,000) were analyzed by U.S. state. Annual change, controlling for seasonal effects, was estimated as the change from the final month of previous year to the final month of the current year (e.g., January 2018 to January 2019). Significance testing was conducted using chi-square tests. Data table provides the annual rate changes by state. Bolded estimates indicate statistically significant results. Rates are suppressed when based on <20 overdoses; for more information, please see: Healthy People 2010 Criteria for Data Suppressionpdf icon.

§ The syndrome definitions used by jurisdictions draw from multiple fields within emergency department (ED) data. Please see more information on the DOSE System tab or CDC’s March 2018 Vital Signs.

¶ The following are several important caveats to consider when interpreting the data presented: (1) Data sent from facilities to health departments may be delayed or may stop for a period of time. When facilities begin sharing data again, information about visits during the lapse may never be shared; (2) For syndromic data, information from ~70% of visits arrive within 48 hours as the chief complaint of the visit. However, the chief complaint field may be incomplete. As updates to visits arrive weeks later, relevant overdose discharge diagnosis codes or revised chief complaint text may be received. Therefore, rates may change over time as the visit records are completed and new drug overdose visits are identified; (3) Because these data are not finalized based on toxicological results, they are not considered confirmed cases, but “suspected” overdoses. Data collected from syndromic surveillance should not be interpreted or represented as exact counts; and (4) Data likely represent an undercount, given inaccuracies in coding and missing chief complaint information.

** The state/territory does not share data from syndromic surveillance systems for DOSE.

†† The funded jurisdiction did not provide CDC enough months of data to calculate all percent change cells.

§§ State does not participate in OD2A DOSE ED data sharing.

CDC’s Drug Overdose Surveillance and Epidemiology (DOSE) System:* Monthly Trends in Emergency Department Visits for Suspected All Stimulants Overdose§, January 2018 to January 2020, by OD2A-funded Jurisdiction

Download Dataexcel icon

January 2018 to February 2018 February 2018 to March 2018 March 2018 to April 2018 April 2018 to May 2018 May 2018 to June 2018 June 2018 to July 2018 July 2018 to August 2018 August 2018 to September 2018 September 2018 to October 2018 October 2018 to November 2018 November 2018 to December 2018 December 2018 to January 2019 January 2019 to February 2019 February 2019 to March 2019 March 2019 to April 2019 April 2019 to May 2019 May 2019 to June 2019 June 2019 to July 2019 July 2019 to August 2019 August 2019 to September 2019 September 2019 to October 2019 October 2019 to November 2019 November 2019 to December 2019 December 2019 to January 2020 Category, December 2019 to January 2020
Monthly Percent Change
(35 states) (35 states) (36 states) (36 states) (36 states) (36 states) (36 states) (36 states) (36 states) (35 states) (36 states) (36 states) (36 states) (37 states) (38 states) (38 states) (39 states) (39 states) (41 states) (41 states) (41 states) (41 states) (41 states) (41 states)
Overall 13.77 14.15 0.96 3.3 5.2 1.96 4.43 -10.33 -8.35 2.78 -2.25 -1.2 8.81 6.22 6.96 6.02 11.04 -4.88 4.42 -6.81 4.61 -7.81 -5.07 -1.29 no significant change
State                                                
Alabama 46.93 -19.85 54.18 -28.16 6.68 2.19 29.98 -3.73 -26.92 39.61 -33.38 32.24 -8.67 11.02 19.66 2.11 -14.45 -6.75 18.87 -17.5 11.29 -10.93 1.87 -28.07 no significant change
Alaska
Arizona 0.83 29.47 -2.43 -15.46 24.49 16.14 -12.78 -12.12 -25.91 11.39 12.64 -13.58 22.82 0.2 -2.57 -4.23 43.31 -4.56 -23.81 -2.85 -12.43 -18.53 -5.01 3.69 no significant change
Arkansas -8.35 9.77 -24.52 51.14 -7.5 7.87 0.74 -23.8 14.67
California**
Colorado -25.46 6.74 -19.31 4.94 no significant change
Connecticut†† -12.35 7.32 -16.65 -14.95 58.62 -22.91 4.52 -14.78 43.56 -5.94 11.33 17.2 -40.84 19.4 no significant change
Delaware†† -1.78 22.84 -21.77 -16.14 13.49 21.41 -20.53 -0.58 56.33 no significant change
District of Columbia 21.72 25.25 -10.81 19.31 -7.85 24.66 -1.85 23.03 -29.28 -32.3 -22.5 -4.72 29.91 -10.39 -5.54 7.63 3.82 -37.11 -8.77 14.11 no significant change
Florida 12.73 9.81 11.97 7.38 6.69 7.16 2.24 -20.21 -5.05 3.35 0.96 -3.74 6.21 13.19 6.28 13.99 17.22 -2.73 -3.72 -1.25 11.62 -9.02 -4.13 -0.09 no significant change
Georgia 25.37 17.75 -7.81 -14.02 11.12 37.91 -24.96 1.01 -26 29.69 -3.15 -3.34 5.88 -20.11 36.87 12.61 -1.23 -1.57 -15 -7.05 -19.38 29.8 -16.33 -20.06 no significant change
Hawaii**
Idaho†† -1.01
Illinois 22.11 33.43 -21.82 24.44 -26.36 23.43 2.72 0.98 -6.33 6.67 0.6 -10.54 0.8 -7.01 24.13 4.53 -12.49 13.57 -1.61 10.2 -13.44 -5.12 -6.78 -8.82 no significant change
Indiana 27.88 17.25 -3.78 -1.95 21.24 -23.92 28.49 2.15 -10.63 -7.33 3.38 -7.76 15.9 1.72 -13.98 15.7 9.56 -1.8 9.85 -7.11 -6.82 -12.84 9.27 15.79 no significant change
Iowa**
Kansas 9.3 28.4 -25.36 11.24 10.35 -6.22 23.61 -19.87 5.3 -5.22 -42.83 29.34 14.94 32.87 5.29 -38.32 74.84 -15.51 -9.67 -7.91 -0.13 -16.67 -18.37 83.94 significant increase
Kentucky†† 39.32 -26.49 -8.77 79.68 2.63 -15.2
Louisiana 2.35 0.15 -27.41 -5.77 5.15 -1.76 -5.01 69.53 -34.41 no significant change
Maine
Maryland†† 19.37 29.78 -3.49 1.57 9.44 -18.45 15.98 -14.55 16.12 -6.03 3.72 9.42 16.04 1.75 2.47 -14.47 4.67 -7.23 -0.28 -29 significant decrease
Massachusetts 62.03 26.05 -8.43 -0.9 6.81 -17.15 24.03 -13.24 -16.49 -17.05 22.48 -9.37 -14.95 65.28 -23.38 11.96 7.15 0.83 5.12 -11.31 -0.23 4.73 28.5 -26.59 no significant change
Michigan -21.9 58.25 28.78 -19.1 -7.53 8.92 6.94 -16.82 -7.47 19.2 -20.69 27.34 42.79 8.06 14.44 7.86 -3.85 -19.42 34.09 -7.74 -8.7 -2.29 19.49 -16.42 no significant change
Minnesota**
Mississippi†† -0.68
Missouri 9.25 38.71 -0.04 -9.14 -22.26 73.13 -30.58 32.25 -24.08 -6.65 5.84 -7.65
Montana
Nebraska**
Nevada -29.5 26.73 9.88 41.54 -34.21 1.72 38.01 -24.25 -9.81 8.68 -20.44 -0.46 22.29 38.57 -21.15 25.71 8.66 -12.95 30.44 -35.67 -5.42 -3.41 13.5 -10.25 no significant change
New Hampshire -23.4 3.02 11.2 1.96
New Jersey 9.15
New Mexico -15.1 15.25 -4.66 -19.45 -12.7 -20.43 19.09 -39.89 19.42 -12.6 12.16 -8.28 no significant change
New York State 2.33 9.97 6.5 0.21 5.01 11.48 -7.31 6.8 7.77 -31.52 -17.98 18.92 24.98 9.97 8.35 -7.68 8.62 -8.25 53.17 -21.13 3.61 -6.52 -9.04 14.11 no significant change
North Carolina 13.7 11.63 8.03 -16.2 22.14 -10.38 6.27 2.11 -19.87 -1.17 11.63 -6.57 -13.61 21.59 -6.66 -15.54 26.83 0.81 -1.06 -17.9 20.34 -21.36 15.82 -4.46 no significant change
North Dakota§§
Ohio 27.57 11.84 -25.15 32.64 -4.4 -20.65 44.5 -23.59 3.18 -0.18 -24.22 52.45 -6.67 -21.35 30.78 -9.1 -12.94 -5.43 39.31 -4.11 8.19 -18.09 -15.21 19.93 no significant change
Oklahoma**
Oregon -21.57 32.52 -20.89 -0.73 29.43 -14.4 35.72 -17.62 5.13 -13.2 -4.1 -2.86 -10.32 23.12 0.31 -14.93 21.28 7.56 -54.73 91.39 -21.43 31.96 no significant change
Pennsylvania 14.53 51.72 -11.46 8 0.19 1.62 17.58 -6.72 -31.41 30.88 8.47 -33.1 34.69 -14.97 23.89 -7.32 22.75 -10.09 16.49 -15.85 29.41 -11.97 -24.58 3.7 no significant change
Puerto Rico**
Rhode Island††
South Carolina†† 8.87 0.83 -17.56 8.99 -30.76 38.17 -2.59 4.7 no significant change
South Dakota
Tennessee 1.27 40.73 -17.71 9.16 9.73 -13.8 22.05 -11.67 0.02 10.27 -10.15 -3.09 22.63 -14.44 14.1 0.44 14.76 -8.24 5.57 -16.51 2.78 -8.78 -3.76 11.57 no significant change
Texas§§
Utah -30.2 -25.72 41.26 40.54 0.97 13.44 1.92 -13.11 -25.5 10.69 0.14 -3.21 26.53 8.7 -5.05 -20.33 28.21 -9.59 -31.81 50.1 8.88 -12.15 -1.72 -0.82 no significant change
Vermont
Virginia 33 -2 -3.33 25.55 16.92 6.63 -5.83 -14.32 -20.22 -3.76 25.32 3.41 -11.25 22.62 2.61 9.48 10.9 -12.45 22.47 -25.23 25.17 -18.83 -77.81 -36.18 no significant change
Washington 34.38 -29.69 30.15 10.87 -16.99 -9.39 -28.29 2.72 20.5 16.64 -33.96 20.87 1.22 3.85 13.88 58.39 14.21 -14.57 38.03 -1.62 -18.79 1.95 -18.83 11.13 no significant change
West Virginia†† -14.14 -6.83 3.43 -21.47 28.62 -7.7 -14.21 12.53 no significant change
Wisconsin†† 14.28 -9.83 4.77 7.14 -7.04 34.19 -21.45 -31.93 13.43 -23.08 no significant change
Wyoming§§

* See DOSE System page.

† To account for changes occurring across time, annual trends for the rate of ED visits involving suspected drug overdoses (e.g., ED visits involving drug overdoses divided by total ED visits and multiplied by 10,000) were analyzed by U.S. state. Annual change, controlling for seasonal effects, was estimated as the change from the final month of previous year to the final month of the current year (e.g., January 2018 to January 2019). Significance testing was conducted using chi-square tests. Data table provides the annual rate changes by state. Bolded estimates indicate statistically significant results. Rates are suppressed when based on <20 overdoses; for more information, please see: Healthy People 2010 Criteria for Data Suppressionpdf icon.

§ The syndrome definitions used by jurisdictions draw from multiple fields within emergency department (ED) data. Please see more information on the DOSE System tab or CDC’s March 2018 Vital Signs.

¶ The following are several important caveats to consider when interpreting the data presented: (1) Data sent from facilities to health departments may be delayed or may stop for a period of time. When facilities begin sharing data again, information about visits during the lapse may never be shared; (2) For syndromic data, information from ~70% of visits arrive within 48 hours as the chief complaint of the visit. However, the chief complaint field may be incomplete. As updates to visits arrive weeks later, relevant overdose discharge diagnosis codes or revised chief complaint text may be received. Therefore, rates may change over time as the visit records are completed and new drug overdose visits are identified; (3) Because these data are not finalized based on toxicological results, they are not considered confirmed cases, but “suspected” overdoses. Data collected from syndromic surveillance should not be interpreted or represented as exact counts; and (4) Data likely represent an undercount, given inaccuracies in coding and missing chief complaint information.

** The state/territory does not share data from syndromic surveillance systems for DOSE.

†† The funded jurisdiction did not provide CDC enough months of data to calculate all percent change cells.

§§ State does not participate in OD2A DOSE ED data sharing.

CDC’s Drug Overdose Surveillance and Epidemiology (DOSE) System:* Annual and Monthly Percent Changes† in Suspected All Stimulants Overdoses§, January 2018 to January 2020 by Sex and Age Group

Download Dataexcel icon

Yearly Percent Change Monthly Percent Change
January 2018 to
January 2019
February 2018 to
February 2019
March 2018 to March 2019 April 2018 to
April 2019
May 2018 to
May 2019
June 2018 to June 2019 July 2018 to July 2019 August 2018 to
August 2019
September 2018 to September 2019 October 2018 to October 2019 November 2018 to November 2019 December 2018 to December 2019 January 2019 to January 2020 Category, January 2019 to January 2020 January 2018 to February 2018 February 2018 to March 2018 March 2018 to April 2018 April 2018 to May 2018 May 2018 to June 2018 June 2018 to July 2018 July 2018 to August 2018 August 2018 to September 2018 September 2018 to October 2018 October 2018 to November 2018 November 2018 to December 2018 December 2018 to January 2019 January 2019 to February 2019 February 2019 to March 2019 March 2019 to April 2019 April 2019 to May 2019 May 2019 to June 2019 June 2019 to July 2019 July 2019 to August 2019 August 2019 to September 2019 September 2019 to October 2019 October 2019 to November 2019 November 2019 to December 2019 December 2019 to January 2020 Category, December 2019 to January 2020
( 32 States ) ( 33 States ) ( 35 States ) ( 35 States ) ( 35 States ) ( 35 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 37 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 35 States ) ( 35 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 35 States ) ( 36 States ) ( 36 States ) ( 36 States ) ( 37 States ) ( 38 States ) ( 38 States ) ( 39 States ) ( 39 States ) ( 41 States ) ( 41 States ) ( 41 States ) ( 41 States ) ( 41 States ) ( 41 States )
CDC’s Drug Overdose Surveillance and Epidemiology (DOSE) System:* Annual and Monthly Percent Changes† in All Stimulant Overdoses§, January 2018 to January 2020¶ by Sex and Age Group
Sex
Male 25.75 18.44 9.48 16.54 19.39 24.8 18.61 17.29 22.07 38.67 27.81 19.77 21.51 significant increase 13.64 12.88 0.45 3.12 6.35 0.38 6.3 -10.32 -6.1 -1.67 2.34 -2.92 7.23 4.46 7.34 5.78 9.82 -3.72 5.15 -6.49 5.75 -8.77 -2.93 -3.1 no significant change
Female 17.68 19.01 10.94 13.69 20.96 31.08 15.94 19.06 21.44 43.63 22.7 24.93 24.83 significant increase 13.34 15.82 2.57 2.35 3.18 4.76 0.65 -9.87 -13.42 13.53 -10.42 2.99 11.49 9.32 5.9 5.95 12.67 -7.35 3.25 -7.49 2.81 -5.35 -9.1 2.79 no significant change
Age group                                            
0-14 38.15 23.45 18.65 10.19 5.11 -1.57 5.55 45.08 41.14 42.91 -29.53 1.68 -4.93 no significant change -1.72 38.91 -3.1 -2.39 10.73 4.53 -21.41 -1.21 -0.31 38.8 -30.75 31.55 -19.93 35.04 -13.06 -6.89 5.13 11.92 9.37 -5.97 -0.01 -31.14 -1.31 26.22 no significant change
15-24 12.35 9.37 10.36 1.82 23.98 22.34 14.63 10.01 0.58 12.92 12.47 17.78 12.62 no significant change 6.24 15.79 4.94 -8.41 1.99 4.31 2.69 -1.3 -9.9 11.73 -14.93 6.54 2.67 16.83 -3.19 12.34 -1.46 -1.95 -1.87 -9.13 0.9 8.45 -10.64 2.16 no significant change
25-34 13.25 6.94 2.12 12.1 9.18 30.93 11.76 12.86 24.58 44.8 27.01 22.78 16.53 significant increase 21.45 6.56 -2.81 7.41 -4.85 6.14 1.14 -10.24 -12.78 13.84 -3.78 -5.58 16.75 1.82 7.54 4.15 12.74 -8.88 3.25 -1.85 1.98 -0.63 -6.3 -11.75 significant decrease
35-54 27.92 20.68 11.06 25.54 24.48 26.79 22.29 25.17 25.95 46.92 30.15 26.12 33.22 significant increase 20.06 13.67 -4.29 7.06 6.54 -5.9 9.95 -9.02 -7.32 1.37 1.71 -5.13 10.95 6.35 8.8 4.35 8.9 -8.13 11.51 -7.78 7.11 -10.08 -0.93 -0.67 no significant change
55 and up 29.66 43.33 38.36 28.88 41.43 48.03 39.36 18.53 33.76 48.21 67.78 26.28 35.84 significant increase 1.48 6.37 14.76 -1.62 9.14 5.54 13.77 -14.05 3.24 -18.93 25.39 -7.08 11.42 1.37 8.12 7.39 13.17 -0.99 -2.53 -2.2 13.64 -8.84 -4.32 -2.19 no significant change

* See DOSE System page.

† To account for changes occurring across time, annual trends for the rate of ED visits involving suspected drug overdoses (e.g., ED visits involving drug overdoses divided by total ED visits and multiplied by 10,000) were analyzed by U.S. state. Annual change, controlling for seasonal effects, was estimated as the change from the final month of previous year to the final month of the current year (e.g., January 2018 to January 2019). Significance testing was conducted using chi-square tests. Data table provides the annual rate changes by state. Bolded estimates indicate statistically significant results. Rates are suppressed when based on <20 overdoses; for more information, please see: Healthy People 2010 Criteria for Data Suppressionpdf icon.

§ The syndrome definitions used by jurisdictions draw from multiple fields within emergency department (ED) data. Please see more information on the DOSE System tab or CDC’s March 2018 Vital Signs.

¶ The following are several important caveats to consider when interpreting the data presented: (1) Data sent from facilities to health departments may be delayed or may stop for a period of time. When facilities begin sharing data again, information about visits during the lapse may never be shared; (2) For syndromic data, information from ~70% of visits arrive within 48 hours as the chief complaint of the visit. However, the chief complaint field may be incomplete. As updates to visits arrive weeks later, relevant overdose discharge diagnosis codes or revised chief complaint text may be received. Therefore, rates may change over time as the visit records are completed and new drug overdose visits are identified; (3) Because these data are not finalized based on toxicological results, they are not considered confirmed cases, but “suspected” overdoses. Data collected from syndromic surveillance should not be interpreted or represented as exact counts; and (4) Data likely represent an undercount, given inaccuracies in coding and missing chief complaint information.

** The state/territory does not share data from syndromic surveillance systems for DOSE.

†† The funded jurisdiction did not provide CDC enough months of data to calculate all percent change cells.

§§ State does not participate in OD2A DOSE ED data sharing.

Access the latest data. Learn what can be done about overdoseand related harms. CDC VitalSigns